Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyoshi Nishikawa

Showing results (171-180 of 197) with videos related to

Pageof 20
Sort By:
Frontiers in Immunology|December 17, 2020
Adult-Onset Anti-Citrullinated Peptide Antibody-Negative Destructive Rheumatoid Arthritis Is Characterized by a Disease-Specific CD8+ T Lymphocyte SignatureTiina Kelkka, Paula Savola, Dipabarna Bhattacharya, et al.
Science Translational Medicine|April 15, 2026
On-demand GLUT3 expression augments CAR T cell metabolic fitness and antitumor efficacy in preclinical models of glioblastomaJunya Yamaguchi, Keisuke Watanabe, Akihiro Nakamura, et al.
Journal for Immunotherapy of Cancer|February 9, 2024
Multiomic molecular characterization of the response to combination immunotherapy in MSS/pMMR metastatic colorectal cancerShogo Takei, Yosuke Tanaka, Yi-Tzu Lin, et al.
Frontiers in Immunology|June 17, 2021
Corrigendum: Adult-Onset Anti-Citrullinated Peptide Antibody-Negative Destructive Rheumatoid Arthritis Is Characterized by a Disease-Specific CD8+ T Lymphocyte SignatureTiina Kelkka, Paula Savola, Dipabarna Bhattacharya, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|March 18, 2020
Enhanced tumor response to radiotherapy after PD-1 blockade in metastatic gastric cancerAkinori Sasaki, Yoshiaki Nakamura, Yosuke Togashi, et al.
International Immunology|July 8, 2021
Novel anti-GARP antibody DS-1055a augments anti-tumor immunity by depleting highly suppressive GARP+ regulatory T cellsKazuki Satoh, Yoichi Kobayashi, Kaori Fujimaki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2022
Preoperative Chemoradiotherapy plus Nivolumab before Surgery in Patients with Microsatellite Stable and Microsatellite Instability-High Locally Advanced Rectal CancerHideaki Bando, Yuichiro Tsukada, Koji Inamori, et al.
Cancer Research|April 18, 2024
CD106 in Tumor-Specific Exhausted CD8+ T Cells Mediates Immunosuppression by Inhibiting TCR SignalingYuto Naoi, Takao Morinaga, Joji Nagasaki, et al.
Annals of Hematology|July 23, 2017
Clinical impact of pre-transplant gut microbial diversity on outcomes of allogeneic hematopoietic stem cell transplantationNoriko Doki, Masahiro Suyama, Satoshi Sasajima, et al.
Cell Reports|February 2, 2022
PD-1 blockade therapy promotes infiltration of tumor-attacking exhausted T cell clonotypesJoji Nagasaki, Takashi Inozume, Nicolas Sax, et al.
Pageof 20

Showing results (171-180 of 197) with videos related to

Sort By:
Pageof 20
Frontiers in Immunology|December 17, 2020
Adult-Onset Anti-Citrullinated Peptide Antibody-Negative Destructive Rheumatoid Arthritis Is Characterized by a Disease-Specific CD8+ T Lymphocyte SignatureTiina Kelkka, Paula Savola, Dipabarna Bhattacharya, et al.
Science Translational Medicine|April 15, 2026
On-demand GLUT3 expression augments CAR T cell metabolic fitness and antitumor efficacy in preclinical models of glioblastomaJunya Yamaguchi, Keisuke Watanabe, Akihiro Nakamura, et al.
Journal for Immunotherapy of Cancer|February 9, 2024
Multiomic molecular characterization of the response to combination immunotherapy in MSS/pMMR metastatic colorectal cancerShogo Takei, Yosuke Tanaka, Yi-Tzu Lin, et al.
Frontiers in Immunology|June 17, 2021
Corrigendum: Adult-Onset Anti-Citrullinated Peptide Antibody-Negative Destructive Rheumatoid Arthritis Is Characterized by a Disease-Specific CD8+ T Lymphocyte SignatureTiina Kelkka, Paula Savola, Dipabarna Bhattacharya, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|March 18, 2020
Enhanced tumor response to radiotherapy after PD-1 blockade in metastatic gastric cancerAkinori Sasaki, Yoshiaki Nakamura, Yosuke Togashi, et al.
International Immunology|July 8, 2021
Novel anti-GARP antibody DS-1055a augments anti-tumor immunity by depleting highly suppressive GARP+ regulatory T cellsKazuki Satoh, Yoichi Kobayashi, Kaori Fujimaki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2022
Preoperative Chemoradiotherapy plus Nivolumab before Surgery in Patients with Microsatellite Stable and Microsatellite Instability-High Locally Advanced Rectal CancerHideaki Bando, Yuichiro Tsukada, Koji Inamori, et al.
Cancer Research|April 18, 2024
CD106 in Tumor-Specific Exhausted CD8+ T Cells Mediates Immunosuppression by Inhibiting TCR SignalingYuto Naoi, Takao Morinaga, Joji Nagasaki, et al.
Annals of Hematology|July 23, 2017
Clinical impact of pre-transplant gut microbial diversity on outcomes of allogeneic hematopoietic stem cell transplantationNoriko Doki, Masahiro Suyama, Satoshi Sasajima, et al.
Cell Reports|February 2, 2022
PD-1 blockade therapy promotes infiltration of tumor-attacking exhausted T cell clonotypesJoji Nagasaki, Takashi Inozume, Nicolas Sax, et al.
Pageof 20